Mid-term Evaluation of Metamorphopsia in Epiretinal Membrane Surgery

Clinica Oculistica dell'Università di Torino

Status: Completed

Conditions: Cataract Senile; Epiretinal Membrane

Treatments: Procedure: Phacoemulsification, intraocular lens implant, vitrectomy.

Study type: Observational

Funder types: Other

Identifiers

NCT03045367

CS/526

Details and patient eligibility

About

This study evaluates the safety and efficacy simultaneous, trans-conjunctival, 25-Gauge vitrectomy and phacoemulsification with intraocular lens implant in patients with metamorphopsia and visual impairment due to idiopathic epiretinal membrane and cataract. All 30 patients recruited underwent complete ocular examination, visual acuity measurement with ETDRS, metamorphopsia assessment with M-Charts and Metamorphometry® and foveal thickness evaluation by sd-OCT preoperatively, at 30, 90, 180 days postoperatively.

Enrollment: 30 patients

Sex: All

Ages: 55 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age > 55 years
• visual acuity ≤ 20/40
• idiopathic epiretinal membrane
• cataract
• Amsler test positive for metamorphopsia.

Exclusion criteria

• previous ocular interventions
• other ocular diseases.

Trial design

30 participants in 1 patient group

Outpatients

Description:

Phacoemulsification, intraocular lens implant, vitrectomy.

Treatment:

Procedure: Phacoemulsification, intraocular lens implant, vitrectomy.